Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
News|Articles|July 1, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-07-06-2016
- Volume 11
- Issue 7
CordenPharma Expands Service Offerings
Author(s)Pharmaceutical Technology Editors
The company expanded its services to include oligonucleotide API development and manufacturing and received approval for its Caponago manufacturing facility.
Advertisement
On July 1, 2016, CordenPharma announced that it has expanded its services to include oligonucleotide API development and manufacturing. The investment was initiated by CordenPharma Colorado and is expected to be complete before the end of 2016, the company said in a
Source: Corden Pharma
Articles in this issue
over 10 years ago
Potential Consequences of the CDMO Acquisition Bingeover 10 years ago
Flow Chemistry Discoveries Advance Continuous Processingover 10 years ago
Excipient Quality Essentialsover 10 years ago
Real-time Monitoring Systems for Drug Shipmentsover 10 years ago
Vessel Improves Dissolution Test Resultsover 10 years ago
Pump Designed for Continuous Processing Scale-upover 10 years ago
Juniper Pharma Services Adds Tablet Pressover 10 years ago
Recipharm Expands Serialization Capabilitiesover 10 years ago
Charles River Acquires Blue Stream Laboratoriesover 10 years ago
Catalent Launches FastChain Service for Clinical Supply ManagementAdvertisement
Related to this article
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap
3
Complying with International Pharmacopoeias
4
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
5